Using Failure Mode, Effect and Criticality Analysis to improve safety in the cancer treatment prescription and administration process

Southern Med Review

article

Buja, Alessandra¹  De Luca, Giuseppe¹  Ottolitri, Ketti²  Marchi, Elena²  De Siena, Francesco Paolo¹  Leone, Giovanni¹  Maculan, Pietro¹  Bolzonella, Umberto¹  Caberlotto, Riccardo¹  Cappella, Giovanni¹  Grotto, Giulia¹  Lattavo, Gaia¹  Sforzi, Benedetta¹  Venturato, Giovanni¹  Saieva, Anna Maria²  Baldo, Vincenzo¹ 

[1]Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua

[2]Veneto Institute of Oncology IOV - IRCCS

关键词: Patient safety;    Proactive management;    Chemotherapy administration;    Cancer treatment;   

DOI  :  10.1186/s40545-023-00512-9

学科分类：药理学

来源: BioMed Central

【 摘 要 】

Administering cancer drugs is a high-risk process, and mistakes can have fatal consequences. Failure Mode, Effect and Criticality Analysis (FMECA) is a widely recognized method for identifying and preventing potential risks, applied in various settings, including healthcare. The aim of this study was to recognize potential failures in cancer treatment prescription and administration, with a view to enabling the adoption of measures to prevent them. This study consists of a FMECA. A team of resident doctors in public health at the University of Padua examined the cancer chemotherapy process with the support of a multidisciplinary team from the Veneto Institute of Oncology (an acknowledged comprehensive cancer center), and two other provincial hospitals. A diagram was drafted to illustrate 9 different phases of chemotherapy, from the adoption of a treatment plan to its administration, and to identify all possible failure modes. Criticality was ascertained by rating severity, frequency and likelihood of a failure being detected, using adapted versions of already published scales. Safety strategies were identified and summarized. Twenty-two failure modes came to light, distributed over the various phases of the cancer treatment process, and seven of them were classified as high risk. All phases of the cancer chemotherapy process were defined as potentially critical and at least one action was identified for a single high-risk failure mode. To reduce the likelihood of the cause, or to improve the chances of a failure mode being detected, a total of 10 recommendations have been identified. FMECA can be useful for identifying potential failures in a process considered to be at high risk. Safety strategies were devised for each high-risk failure mode identified. FMECA is a proactive risk assessment tool that has proved useful in identifying potential failures in the process of prescribing and administering cancer treatments, which is a high-risk process. The analysis evidenced 22 failures modes, distributed over the various phases of the process. In order to reduce the likelihood of the cause, or to improve the chances of a failure mode being detected, this work identified a number of recommendations to be adopted in the administration of cancer treatment in an outpatient setting.

【 授权许可】

Unknown